Acute Lymphoblastic Leukemia
Unrelated stem cell grafts improve survival for children with high recurrence risk
Published in Cancer Weekly, July 1st, 2003
"Allogeneic stem cell transplantation (SCT) is frequently considered as treatment for relapsed childhood" ALL, researchers in Germany explained. "For patients without a matched sibling donor, SCT from unrelated donors (UD-SCT) has been increasingly performed during the past years."
"However, UD-SCT-related mortality and morbidity is still considerable, and the question remains as to which patients are at such high risk of recurrence that UD-SCT is indicated and, conversely, which patients do not require transplantation for long-term...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-07-01)
More Articles from Cancer Weekly
- Cancer Metastasis
Researchers successfully inhibit spread of cancer in mice - Cancer Therapy
Engineered adenoviruses selectively destroys tumor cells - AIDS-related Lymphoma
HAART appears to have caused biological shift towards more treatable disease - Apoptosis
Silent DNA architecture helps block cancer cell growth - Prostate Cancer
'Lost' protein may lead to new treatment - Women's Health
Primary ovarian cancer spheroids host replicative adenovirus targeting integrin - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
